Speaker(s): 

Queeneth C. Uwandu, MD, Internal Medicine Resident, Staff Member, Geisinger - has nothing to disclose.

Moderator(s): 

Connor Dougherty, DO, Staff Member, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Define and Explore the concept of opioid-induced hyperalgesia (OIH) to enhance understanding
2. Review Neurobiological mechanisms underlying OIH, potential impact on pain management strategies, current interventions, and treatment modalities 
3. Discuss clinical implications of OIH, importance of recognizing and addressing this phenomenon for more effective patient care.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Conner Dougherty, DO; Karlyn Paglia, MD; Juan R. Escobar, MD; Shashank Kotakonda, MD; Jayalakshmi Nair, MD; Jignesh Patel, MD; Jameson Woodard, MD; Hasan Zerti, MD and Eric Drago, MD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.